These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 37790551)

  • 21. High levels of pro-inflammatory SARS-CoV-2-specific biomarkers revealed by in vitro whole blood cytokine release assay (CRA) in recovered and long-COVID-19 patients.
    Gomes SMR; Brito ACS; Manfro WFP; Ribeiro-Alves M; Ribeiro RSA; da Cal MS; Lisboa VDC; Abreu DPB; Castilho LDR; Porto LCMS; Mafort TT; Lopes AJ; da Silva SAG; Dutra PML; Rodrigues LS
    PLoS One; 2023; 18(4):e0283983. PubMed ID: 37018291
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An intranasal influenza virus-vectored vaccine prevents SARS-CoV-2 replication in respiratory tissues of mice and hamsters.
    Deng S; Liu Y; Tam RC; Chen P; Zhang AJ; Mok BW; Long T; Kukic A; Zhou R; Xu H; Song W; Chan JF; To KK; Chen Z; Yuen KY; Wang P; Chen H
    Nat Commun; 2023 Apr; 14(1):2081. PubMed ID: 37045873
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mild respiratory COVID can cause multi-lineage neural cell and myelin dysregulation.
    Fernández-Castañeda A; Lu P; Geraghty AC; Song E; Lee MH; Wood J; O'Dea MR; Dutton S; Shamardani K; Nwangwu K; Mancusi R; Yalçın B; Taylor KR; Acosta-Alvarez L; Malacon K; Keough MB; Ni L; Woo PJ; Contreras-Esquivel D; Toland AMS; Gehlhausen JR; Klein J; Takahashi T; Silva J; Israelow B; Lucas C; Mao T; Peña-Hernández MA; Tabachnikova A; Homer RJ; Tabacof L; Tosto-Mancuso J; Breyman E; Kontorovich A; McCarthy D; Quezado M; Vogel H; Hefti MM; Perl DP; Liddelow S; Folkerth R; Putrino D; Nath A; Iwasaki A; Monje M
    Cell; 2022 Jul; 185(14):2452-2468.e16. PubMed ID: 35768006
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical Approach to Post-acute Sequelae After COVID-19 Infection and Vaccination.
    Hulscher N; Procter BC; Wynn C; McCullough PA
    Cureus; 2023 Nov; 15(11):e49204. PubMed ID: 38024037
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intranasal vaccination induced cross-protective secretory IgA antibodies against SARS-CoV-2 variants with reducing the potential risk of lung eosinophilic immunopathology.
    Hemmi T; Ainai A; Hashiguchi T; Tobiume M; Kanno T; Iwata-Yoshikawa N; Iida S; Sato Y; Miyamoto S; Ueno A; Sano K; Saito S; Shiwa-Sudo N; Nagata N; Tamura K; Suzuki R; Hasegawa H; Suzuki T
    Vaccine; 2022 Sep; 40(41):5892-5903. PubMed ID: 36064667
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Higher pro-inflammatory cytokines IL-6 and IFN-γ are associated with anti-SARS-CoV-2 spike protein-specific seroconversion in renal allograft recipients.
    Yadav B; Prasad N; Kushwaha RS; Patel MR; Bhadauria D; Kaul A
    Transpl Infect Dis; 2023 Oct; 25(5):e14133. PubMed ID: 37605477
    [TBL] [Abstract][Full Text] [Related]  

  • 27. mRNA vaccine-induced T cells respond identically to SARS-CoV-2 variants of concern but differ in longevity and homing properties depending on prior infection status.
    Neidleman J; Luo X; McGregor M; Xie G; Murray V; Greene WC; Lee SA; Roan NR
    Elife; 2021 Oct; 10():. PubMed ID: 34636722
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Complement Activation Contributes to Severe Acute Respiratory Syndrome Coronavirus Pathogenesis.
    Gralinski LE; Sheahan TP; Morrison TE; Menachery VD; Jensen K; Leist SR; Whitmore A; Heise MT; Baric RS
    mBio; 2018 Oct; 9(5):. PubMed ID: 30301856
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Defending against SARS-CoV-2: The T cell perspective.
    Almendro-Vázquez P; Laguna-Goya R; Paz-Artal E
    Front Immunol; 2023; 14():1107803. PubMed ID: 36776863
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Acute transient cognitive dysfunction and acute brain injury induced by systemic inflammation occur by dissociable IL-1-dependent mechanisms.
    Skelly DT; Griffin ÉW; Murray CL; Harney S; O'Boyle C; Hennessy E; Dansereau MA; Nazmi A; Tortorelli L; Rawlins JN; Bannerman DM; Cunningham C
    Mol Psychiatry; 2019 Oct; 24(10):1533-1548. PubMed ID: 29875474
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Humoral and cellular immune responses in fully vaccinated individuals with or without SARS-CoV-2 breakthrough infection: Results from the CoV-ADAPT cohort.
    Hollstein MM; Dierks S; Schön MP; Bergmann A; Abratis A; Eidizadeh A; Kaltenbach S; Schanz J; Groß U; Leha A; Kröger A; Andag R; Zautner AE; Fischer A; Erpenbeck L; Schnelle M
    J Med Virol; 2023 Oct; 95(10):e29122. PubMed ID: 37787583
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunization with 674-685 fragment of SARS-Cov-2 spike protein induces neuroinflammation and impairs episodic memory of mice.
    Lykhmus O; Kalashnyk O; Koval L; Krynina O; Komisarenko S; Skok M
    Biochem Biophys Res Commun; 2022 Sep; 622():57-63. PubMed ID: 35843095
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effectiveness of ChAdOx1 nCoV-19 vaccine against SARS-CoV-2 infection during the delta (B.1.617.2) variant surge in India: a test-negative, case-control study and a mechanistic study of post-vaccination immune responses.
    Thiruvengadam R; Awasthi A; Medigeshi G; Bhattacharya S; Mani S; Sivasubbu S; Shrivastava T; Samal S; Rathna Murugesan D; Koundinya Desiraju B; Kshetrapal P; Pandey R; Scaria V; Kumar Malik P; Taneja J; Binayke A; Vohra T; Zaheer A; Rathore D; Ahmad Khan N; Shaman H; Ahmed S; Kumar R; Deshpande S; Subramani C; Wadhwa N; Gupta N; Pandey AK; Bhattacharya J; Agrawal A; Vrati S; Bhatnagar S; Garg PK;
    Lancet Infect Dis; 2022 Apr; 22(4):473-482. PubMed ID: 34838183
    [TBL] [Abstract][Full Text] [Related]  

  • 34. SARS-CoV-2 spike S1 subunit induces neuroinflammatory, microglial and behavioral sickness responses: Evidence of PAMP-like properties.
    Frank MG; Nguyen KH; Ball JB; Hopkins S; Kelley T; Baratta MV; Fleshner M; Maier SF
    Brain Behav Immun; 2022 Feb; 100():267-277. PubMed ID: 34915155
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A Nutritional Blend Suppresses the Inflammatory Response from Bronchial Epithelial Cells Induced by SARS-CoV-2.
    Mateus-Silva JR; Oliveira CR; Brandao-Rangel MAR; Silva-Reis A; Olimpio FRDS; Zamarioli LDS; Aimbire F; Vieira RP
    J Diet Suppl; 2023; 20(2):156-170. PubMed ID: 35930300
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-lived macrophage reprogramming drives spike protein-mediated inflammasome activation in COVID-19.
    Theobald SJ; Simonis A; Georgomanolis T; Kreer C; Zehner M; Eisfeld HS; Albert MC; Chhen J; Motameny S; Erger F; Fischer J; Malin JJ; Gräb J; Winter S; Pouikli A; David F; Böll B; Koehler P; Vanshylla K; Gruell H; Suárez I; Hallek M; Fätkenheuer G; Jung N; Cornely OA; Lehmann C; Tessarz P; Altmüller J; Nürnberg P; Kashkar H; Klein F; Koch M; Rybniker J
    EMBO Mol Med; 2021 Aug; 13(8):e14150. PubMed ID: 34133077
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Third SARS-CoV-2 vaccination and breakthrough infections enhance humoral and cellular immunity against variants of concern.
    Ruhl L; Kühne JF; Beushausen K; Keil J; Christoph S; Sauer J; Falk CS
    Front Immunol; 2023; 14():1120010. PubMed ID: 37033958
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Persistent but dysfunctional mucosal SARS-CoV-2-specific IgA and low lung IL-1β associate with COVID-19 fatal outcome: A cross-sectional analysis.
    Ruiz MJ; Siracusano G; Cottignies-Calamarte A; Tudor D; Real F; Zhu A; Pastori C; Capron C; Rosenberg AR; Temperton N; Cantoni D; Liao H; Ternette N; Moine P; Godement M; Geri G; Chiche JD; Annane D; Cramer Bordé E; Lopalco L; Bomsel M
    Front Immunol; 2022; 13():842468. PubMed ID: 36248831
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Immune Response to SARS-CoV-2 Vaccination: Insights Learned From Adult Patients With Common Variable Immune Deficiency.
    Quinti I; Locatelli F; Carsetti R
    Front Immunol; 2021; 12():815404. PubMed ID: 35126372
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Enhanced mucosal immune responses and reduced viral load in the respiratory tract of ferrets to intranasal lipid nanoparticle-based SARS-CoV-2 proteins and mRNA vaccines.
    Boley PA; Lee CM; Schrock J; Yadav KK; Patil V; Suresh R; Lu S; Feng MM; Hanson J; Channappanavar R; Kenney SP; Renukaradhya GJ
    J Nanobiotechnology; 2023 Feb; 21(1):60. PubMed ID: 36814238
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.